2022
DOI: 10.1186/s12955-022-02043-4
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of problems reported on the EQ-5D-3L dimensions among people with impaired vision in northern Portugal

Abstract: Background The EQ-5D index often fails to detect the effect of ophthalmic diseases and sight loss. Investigating predictors of individual EQ-5D health dimensions might reveal the underlying reasons. The aim of this study was to investigate predictors of health dimension ratings obtained with the EQ-5D-3L from participants with impaired vision representing a spectrum of eye diseases. Methods Observational cross-sectional study with participants recr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 61 publications
0
2
0
Order By: Relevance
“…Their EQ-5D-5L index scores were also similar to those of adults with other chronic eye diseases (Langelaan et al, 2007 ; Senra et al, 2022 ). Pain/discomfort was the most frequently (65%) affected health domain of the EQ-5D-5L, and pain/discomfort appeared higher in this aniridia sample than in other populations with ophthalmic diseases (Langelaan et al, 2007 ; Macedo et al, 2022 ). The EQ-5D-5L has been widely used in quality-of-life research in populations with chronic conditions and ophthalmic diseases (Langelaan et al, 2007 ; Senra et al, 2022 ; Zhou et al, 2021 ).…”
Section: Discussionmentioning
confidence: 59%
“…Their EQ-5D-5L index scores were also similar to those of adults with other chronic eye diseases (Langelaan et al, 2007 ; Senra et al, 2022 ). Pain/discomfort was the most frequently (65%) affected health domain of the EQ-5D-5L, and pain/discomfort appeared higher in this aniridia sample than in other populations with ophthalmic diseases (Langelaan et al, 2007 ; Macedo et al, 2022 ). The EQ-5D-5L has been widely used in quality-of-life research in populations with chronic conditions and ophthalmic diseases (Langelaan et al, 2007 ; Senra et al, 2022 ; Zhou et al, 2021 ).…”
Section: Discussionmentioning
confidence: 59%
“…This suggests that EQ-5D-5L utility values may not be sensitive to the reduced quality of life associated with all types and stages of vision impairment due to IRDs. This lack of discrimination has also been noted when assessing the EQ-5D-3L among people with neovascular age-related macular degeneration (Payakachat et al, 2009), primary open-angle glaucoma (Browne et al, 2012), diabetic macular oedema (Kay & Ferreira, 2014) and other causes of low vision (Lin & Yu, 2012;Macedo et al, 2022), along with a lack of responsiveness to low vision rehabilitation (Malkin et al, 2013). To our knowledge, the EQ-5D-5L and NEI-VFQ have not been compared in people with IRDs to date.…”
Section: Discussionmentioning
confidence: 91%
“…The EQ-5D-5L index has been considered to have low responsiveness to the effects of vision rehabilitation; therefore, our results for the cost-effectiveness have limitations [38,73]. The fact that we used the EQ-5D-5L, an instrument with limited responsiveness to vision rehabilitation, is a limitation to the results of the current trial [74].…”
Section: Clinical Impact Of Rehabilitationmentioning
confidence: 87%